Brenda Latowsky, MD
Procedural Dermatology · Scottsdale, AZNPI 1306010467
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $116,562 of the $152,286 with a category attached, or 76.5%. AbbVie accounts for 75.6% of it on its own, with 38 other manufacturers making up the rest.
Across 572 payments — averaging $266.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$115K
- Galderma Laboratories, L.p.$15K
- Merz North America, Inc.$11K
- Noctrix Health, Inc.$3K
- Strata Skin Sciences, Inc.$3K
- Revance Therapeutics, Inc.$1K
- plus $4K from 33 others
Across 534 payments — averaging $6601.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3M
- Eli Lilly$144K
- Endo Pharmaceuticals Inc.$134K
- Galderma Laboratories, L.p.$107K
- Dermavant Sciences, Inc.$41K
- Arcutis Biotherapeutics, Inc.$26K
- plus $45K from 6 others
What the payments were for
- Consulting fees$116,56277%
- Speaking & faculty fees$9,0196%
- Travel & lodging$9,0276%
- Food & beverage$17,49711%
- Education$1820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few procedural dermatology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 21 | $150 |
| Fluocinonide | 13 | $111 |
| Doxycycline Hyclate | 17 | $106 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Scottsdale
- Anne GoldsberryScottsdale$5K
- Glenn ZellmanPhoenix$1M
- Jody ComstockTucson$155K
- Marc EpsteinTucson$13K
- Ronald MannTucson$5K
- Jordan MillerFlagstaff$4K
- Madeline ParsonPhoenix$3K
- Ryan ProctorBullhead City$2K
- Keith MackenziePrescott$1K
- Neel PatelPhoenix$828
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.